Heparin is an anticoagulant and acts by potentiating the naturally occurring inhibitors of thrombin and factor X (Xa). Heparin Sodium 10 I.U./ml Flushing Solution is indicated in any clinical circumstances in which it is desired to maintain the patency of indwelling catheters/cannulae, attendant lines or heparin locks.
The FDA has given approval for the Abbreviated New Drug Application (ANDA) for acetylcysteine injection, from APP Pharma, indicated to...
Mylan N.V. announced that the FDA has approved Mylan's Abbreviated New Drug Applications (ANDAs) for Glatiramer Acetate Injection 40 mg/mL...
Roche announced data from the Phase III OCARINA II study (S31.006) of Ocrevus (ocrevuslizumab), an investigational twice-yearly, 10-minute subcutaneous (SC) injection
Kaleo (formerly Intelliject) announced that the FDA has approved Evzio (naloxone hydrochloride injection) for the emergency treatment of known or...
Eton Pharmaceuticals announced that the FDA has accepted for review the Company’s New Drug Application (NDA) response for dehydrated alcohol injection for the proposed indication of methanol poisoning
The FDA has approved Eli Lilly's Humulin R U-500 KwikPen (insulin human injection) 500 units/mL, a pre-filled device containing Humulin...
MAIA Pharmaceuticals announced the Tentative Approval of its sincalide for Injection NDA by the FDA. MAIA's sincalide for Injection is...